Sorin Group Sells Non-Core Assets To Cytomedix
Sorin Group said that the Angel product line consists of a blood processing device and disposable products used for separation of whole blood into red cells, platelet poor
The US Food and Drug Administration (FDA) has approved two Jazz Pharmaceuticals regimens containing Ziihera (zanidatamab-hrii) for the first-line treatment of adults with unresectable, locally advanced or metastatic human epidermal growth factor receptor 2 (HER2)-positive gastroesophageal adenocarcinoma (GEA).
The LaPorte plant is a multi-purpose manufacturing facility specialising in the production of registered intermediates and active pharmaceutical ingredients (APIs) for the pharmaceutical industry. AMPAC Fine Chemicals claimed